Gold Kelly
Chief Financial Officer
Gold Kelly has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Sep 2, 2026.
On the most recent filing, Gold Kelly is listed as Chief Financial Officer at Camp4 Therapeutics Corp. Inside the rolling window, Gold Kelly reported 2 open-market purchases totaling $50K in CAMP and no open-market sales. The largest disclosed transaction in the window is a purchase of 10,000 CAMP shares on Aug 31, 2026, worth $40K.
Companies traded
Other insiders at CAMP
Insider Buying
$50K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 11, 2025 | CAMP | Purchase | $10K |
Frequently asked questions
How many SEC Form 4 filings has Gold Kelly made?
Gold Kelly has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.
Which companies does Gold Kelly trade?
Gold Kelly has filed SEC Form 4 disclosures for 1 company, including CAMP.
When was Gold Kelly's most recent SEC Form 4 filing?
Gold Kelly's most recent SEC Form 4 filing on Tracefour is dated Sep 2, 2026.
What is Gold Kelly's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Gold Kelly is listed as Chief Financial Officer.
What is Gold Kelly's total buy and sell value in the current window?
Inside the rolling retention window, Gold Kelly bought $50K and sold $0 based on SEC Form 4 filings.
What was Gold Kelly's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 10,000 CAMP shares on 2026-08-31, worth $40K, per SEC Form 4 filings.